Weiliang Lu

机构：Guangxi Maternal and Child Health Hospital · ORCID：0000-0002-8671-8413

发表论文 29 篇 · 总被引 710 次 · h-index 13

代表论文

• Loss of hnRNPA2B1 inhibits malignant capability and promotes apoptosis via down-regulating Lin28B expression in ovarian cancer (2020 · Cancer Letters · 被引 98)
• PGK1 contributes to tumorigenesis and sorafenib resistance of renal clear cell carcinoma via activating CXCR4/ERK signaling pathway and accelerating glycolysis (2022 · Cell Death and Disease · 被引 92)
• Prospective prenatal cell-free DNA screening for genetic conditions of heterogenous etiologies (2024 · Nature Medicine · 被引 60)
• Genetic deconvolution of fetal and maternal cell-free DNA in maternal plasma enables next-generation non-invasive prenatal screening (2022 · Cell Discovery · 被引 41)
• Association of prenatal renal ultrasound abnormalities with pathogenic copy number variants in a large Chinese cohort (2021 · Ultrasound in Obstetrics and Gynecology · 被引 35)
• CNV profiles of Chinese pediatric patients with developmental disorders (2021 · Genetics in Medicine · 被引 34)